Thyrocare Technologies Ltd
company logo

Thyrocare Technologies Ltd

Small Cap


- (0%)

Thyrocare Technologies Ltd Performance










Thyrocare Technologies Ltd Fundamentals








i buttonClick here to know more about Fundamentals

Thyrocare Technologies Ltd Financials

Thyrocare Technologies Ltd Financialsright-arrow

Thyrocare Technologies Ltd Shareholding Pattern

Thyrocare Technologies Ltd Delivery and Volume

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in the year January 28, 2000. The Company is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. As of 31 March




GOPAL SHIVRAM HEGDEIndependent Director
Neetin Shivajirao DesaiIndependent Director
RAMJEE DORAICompany Sec. & Compli. Officer
Indumati GopinathanIndependent Director
Dhaval ShahNon-Exec & Non-Independent Dir
Dharmil ShethNon-Exec & Non-Independent Dir
Rahul GuhaChairman & MD & CEO
Hardik DedhiaNon-Exec & Non-Independent Dir
Prapti Ishwar GiladaIndependent Director
Harshil Jiten VoraIndependent Director
News and Events...

Similar Stocks

What's Trending

Thyrocare Technologies Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Thyrocare Technologies Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Thyrocare Technologies Ltd's share price is ₹637.8 as of 2024-07-13.
Thyrocare Technologies Ltd's P/E ratio is 47.81 times as of 2024-07-13.
Thyrocare Technologies Ltd's most recent financial reports indicate a price-to-book ratio of 6.42, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Thyrocare Technologies Ltd's market capitalization is ₹3382.62 Cr as on 2024-07-13.
The current financial records of Thyrocare Technologies Ltd show a 10.94% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Thyrocare Technologies Ltd's most recent financial filings, the company has a total asset value of ₹156.23, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Thyrocare Technologies Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Thyrocare Technologies Ltd's 52-week high and low as of 2024-07-13 are ₹651.25 and ₹632.1, respectively.